What is the appropriate diagnostic workup and management for a 13-year-old female presenting with a two‑week non‑productive cough, weakness, and dorsal finger lesions that could represent a fungal infection or allergic contact dermatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diagnostic Workup and Management

This presentation of non-productive cough, weakness, and dorsal finger lesions in a 13-year-old female requires immediate evaluation for systemic fungal infection, particularly invasive aspergillosis, which can present with these exact features and carries significant mortality risk if diagnosis is delayed.

Initial Assessment Priority

The combination of respiratory symptoms with skin lesions and constitutional symptoms (weakness) raises concern for a systemic process rather than isolated dermatologic or respiratory conditions. While the cough duration of 2 weeks doesn't yet meet the chronic cough threshold (>4 weeks) defined in pediatric guidelines 1, the presence of skin lesions and weakness suggests a more urgent systemic evaluation is warranted.

Critical Red Flags to Assess Immediately:

  • Immunocompromised state: Any history of recurrent infections, underlying conditions, or medication use
  • Eosinophilia: Can indicate fungal sensitization or infection 2
  • Fever pattern: Even low-grade fevers with respiratory symptoms warrant fungal consideration 2
  • Progressive weakness: Suggests systemic involvement beyond localized infection

Diagnostic Workup Algorithm

First-Line Investigations:

  1. Complete blood count with differential

    • Look specifically for eosinophilia, which has been associated with invasive aspergillosis even in immunocompetent patients 2
    • Assess for leukocytosis or immunosuppression markers
  2. Chest imaging (X-ray initially, CT if abnormal)

    • Upper lobe consolidation or mediastinal involvement suggests fungal etiology 2
    • Even immunocompetent adolescents can develop invasive pulmonary aspergillosis 2
  3. Inflammatory markers

    • CRP and procalcitonin (procalcitonin <1 ng/mL with elevated CRP suggests fungal over bacterial infection) 3
  4. Skin lesion evaluation

    • Potassium hydroxide (KOH) preparation of skin scrapings from finger lesions
    • Fungal culture from skin lesions
    • Consider skin biopsy if initial tests negative but suspicion remains high

Second-Line Investigations (if initial workup suggests fungal infection):

  1. Aspergillus-specific testing

    • Serum galactomannan antigen
    • Aspergillus PCR from blood 3
    • Beta-D-glucan (though less specific)
  2. Respiratory sampling

    • Induced sputum for fungal culture and PCR
    • Bronchoalveolar lavage (BAL) with Aspergillus DNA detection if imaging abnormal 3
    • Look for basidiomycetous fungi, which can cause chronic cough with fungal colonization 4
  3. Contact dermatitis evaluation (if fungal workup negative)

    • Detailed exposure history: cosmetics, personal care products, topical medications, clothing, gloves 5
    • Occupational/recreational exposures 5
    • Consider patch testing only after acute phase resolves 5

Management Approach

If Fungal Infection Suspected or Confirmed:

Initiate antifungal therapy immediately without waiting for culture confirmation if clinical suspicion is high, as delayed treatment significantly increases mortality 2.

  • First-line: Voriconazole (preferred for aspergillosis in adolescents)
  • Alternative: Liposomal amphotericin B if severe presentation 6
  • Consider adding caspofungin if inadequate response to amphotericin B alone 3

Critical caveat: A case report demonstrated fatal outcome in an 18-year-old immunocompetent female with invasive aspergillosis despite amphotericin B therapy started one day before death, emphasizing the importance of early recognition 2.

If Contact Dermatitis More Likely:

Only pursue this diagnosis after excluding systemic fungal infection, given the higher morbidity/mortality risk of missed fungal disease.

  • Allergen/irritant avoidance is paramount 5
  • Topical corticosteroids for skin lesions 7
  • Emollients for barrier restoration 7
  • Address any wash products containing harsh surfactants that damage skin barrier 5

Common Pitfalls to Avoid

  1. Assuming immunocompetence excludes invasive fungal infection: Multiple case reports demonstrate invasive aspergillosis in immunocompetent adolescents 2, 6

  2. Waiting for chronic cough criteria (>4 weeks) before investigating: The presence of systemic symptoms and skin lesions mandates earlier investigation 1

  3. Attributing all symptoms to contact dermatitis: The combination of respiratory and dermatologic symptoms with weakness suggests systemic disease

  4. Delaying antifungal therapy pending culture results: If clinical suspicion is high, empiric therapy should begin immediately 2

  5. Missing underlying immunodeficiency: Diagnosis of invasive fungal infection should prompt evaluation for conditions like chronic granulomatous disease 6

Specific Concerns to Address in History

  • Atopic history: Personal or family history of atopy, asthma, hay fever 5
  • Environmental exposures: Wood decay fungi (Bjerkandera adusta), mushroom spores 4
  • Product exposures: Nickel, fragrances, cobalt in jewelry or clothing 5
  • Geographic exposures: Endemic fungal infections (though less likely with finger lesions)

The threshold for fungal investigation should be low in this presentation, as the mortality risk of missed invasive aspergillosis far outweighs the risks of diagnostic workup and empiric antifungal therapy.

Related Questions

What is the appropriate management for a 21‑month‑old child with a 10‑day history of cough and rhinorrhea who now has fever?
What is the appropriate treatment plan and its rationale for a 2-year-old child presenting with cough, fever, right-ear otorrhea, and rhinorrhea?
What focused pediatric assessment (interview, OPQRST, review of systems, physical exam, and assessment and plan) is recommended for a 3‑year‑old female presenting with cough and sore throat?
What is the likely cause and recommended management for a 9-year-old girl with five days of intermittent fever, a normal throat and chest on examination, and a two-day history of cough?
A previously healthy 16-year-old male presents with fever, rhinorrhea, dry cough, and loose stools for four days. What is the most likely diagnosis and recommended treatment?
Are there any studies or guidelines regarding breakthrough herpes zoster in individuals who have received the recombinant zoster vaccine (Shingrix)?
In a 50-year-old male with erectile dysfunction, a good marital relationship, stable life circumstances, borderline hypertension, and obesity, how should a phosphodiesterase‑5 inhibitor be initiated and managed?
What is the likely diagnosis and recommended management for a 6-year-old white child with a few small telangiectasias on the cheek?
In a 13‑year‑old girl with a two‑week non‑productive cough, generalized weakness, and dorsal finger lesions, what does a high‑resolution CT scan showing only mild inflammatory changes without consolidation indicate, and what are the appropriate next diagnostic and treatment steps?
What is the chronic kidney disease of unknown origin (CKDu) affecting farm workers in Texas?
What are the diagnostic criteria for primary Sjögren’s syndrome?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.